CVE-2025-61940: NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database…
CVE-2025-61940 · Severity: high · CVSS 8.3 · Published 2025-12-02
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
No. Junglewise Threat Intelligence has no report of CVE-2025-61940 being exploited in the wild.
How severe is CVE-2025-61940?
High severity, with a CVSS score of 8.3, published 2 December 2025.
Which products and versions are affected?
Mirion Biodose\, Mirion Nmis. The advisory does not name versions.
Is there a fix for CVE-2025-61940?
No fixed version is recorded yet. Check the vendor's advisory in the references below. If you run it, Junglewise drafts a mitigation that fits your setup and applies it once you approve, with senior security engineers behind it.
Am I affected by CVE-2025-61940?
Check whether you run Mirion Biodose\ or Mirion Nmis. Junglewise does that check for you around the clock: connect your code, cloud and domains, and it matches new vulnerabilities like this one against what you actually run and tells you when one reaches you.